MEC Practice Academy 11.19
|Articles|April 4, 2016

Premium Content Preview | The Evolving EPCS Landscape: A Prescription for Stopping Opioid Abuse

This new industry briefing from DrFirst highlights trends and advances with electronic prescribing of controlled substances (EPCS), and reveals that retail pharmacies have adopted EPCS technology at a swift pace, while providers lag far behind. While the majority of U.S. pharmacies are EPCS enabled, only about six percent of prescribers nationwide have this ability-despite the fact that roughly 90 percent of EHRs are EPCS-enabled. It also shows how prescribers in New York are scrambling to comply with the state’s new EPCS mandate.

 

This new industry briefing from DrFirst highlights trends and advances with electronic prescribing of controlled substances (EPCS), and reveals that retail pharmacies have adopted EPCS technology at a swift pace, while providers lag far behind. While the majority of U.S. pharmacies are EPCS enabled, only about six percent of prescribers nationwide have this ability-despite the fact that roughly 90 percent of EHRs are EPCS-enabled. It also shows how prescribers in New York are scrambling to comply with the state’s new EPCS mandate.

 

Download to view the entire whitepaper

 

 

 

 

 

 

 

Related to this article

Stroke survivors get a first-of-its-kind anticoagulant; Queens day care director admits $127M Medicare, Medicaid fraud; ovarian cancer may leave an early mark in the blood — Morning Medical Update © kwanchaichaiudom - stock.adobe.com
The top news stories in medicine today: The FDA approves the first factor XIa inhibitor to reduce the risk of a repeat stroke; a Queens adult day care program director pleads guilty in a $127 million Medicare and Medicaid fraud scheme; researchers tie a blood RNA signal to the precancerous stage of ovarian cancer.